Firma ADVITOS, Autor bei PR-Web

ADVITOS wins two Red Dot Awards for the design of the new ADVOS BK300 – Next-Level Blood Purification convinces internationally

Posted on 30. April 20251. May 2025 by Firma ADVITOS Posted in General Tagged advitos, advos, award, bk300, blood, clinical, company, dot, liver, medical, new, renal, therapy, treatment, with

ADVITOS GmbH, a medical technology company specialising in extracorporeal therapy systems, has received two prestigious Red Dot Awards 2025 for its latest generation of ADVOS BK300 devices: the Product Design Award and the Innovative Design Award. This honours the pioneering […]

Personnel Boost in Effective Multi-Organ Support

Posted on 28. January 2022 by Firma ADVITOS Posted in General Tagged advitos, advos, clinical, company, medical, multi organ failure, multi-organ, munich, new, Personnel, therapy, treatment

ADVITOS enjoys a well-earned reputation in the field of medical technology on the back of its self-developed ADVOS procedure – the 4-in-1 organ support for the treatment of multi-organ failure. The special properties along with the USPs of the ADVanced […]

New study: organ support therapy ADVOS normalizes acid-base balance in COVID-19 patients

Posted on 11. August 202112. August 2021 by Firma ADVITOS Posted in General Tagged advos, blood, clinical, covid, kidney, liver, medical, new, patients, respiratory, therapy, treatment

Impaired oxygenation is the most common clinical presentation in COVID-19 patients, however, some of them also develop problems with carbon dioxide removal. This contributes to acid-base imbalance, one of the strongest risk factors for critically ill patients. ADVOS procedure supports […]

Multi-organ failure: innovative 4-in-1 therapy from ADVITOS receives funding

Posted on 10. June 202110. June 2021 by Firma ADVITOS Posted in General Tagged advitos, advos, cmi, dialysis, eic, financing, liver, multi organ failure, patients

ADVITOS GmbH (“ADVITOS”), a Munich-based medical technology company, today announced the completion of a EUR 20 million financing round. The financing round was led by Crédit Mutuel Equity via its two subsidiaries Crédit Mutuel Equity Germany and Crédit Mutuel Innovation. […]